Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentraxin alfa-Reference-Cited by-同舟云学术

Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentraxin alfa

Published:2024-06 Issue:6 Volume:8 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:HemaSphere

Author:

Ryou Hosuk¹,Sirinukunwattana Korsuk²,Wood Ruby³,Aberdeen Alan²^ORCID,Rittscher Jens²³⁴⁵⁶,Weinberg Olga K.⁷,Hasserjian Robert⁸,Pozdnyakova Olga⁹,Peale Frank¹⁰,Higgins Brian¹⁰,Lundberg Pontus¹¹,Trunzer Kerstin¹¹,Harrison Claire N.¹²,Royston Daniel¹³^ORCID

Affiliation:

1. Nuffield Department of Medicine University of Oxford Oxford UK

2. Ground Truth Labs, Ltd. Oxford UK

3. Institute of Biomedical Engineering (IBME), Department of Engineering Science University of Oxford Oxford UK

4. Big Data Institute/Li Ka Shing Centre for Health Information and Discovery University of Oxford Oxford UK

5. Oxford NIHR Biomedical Research Centre Oxford University Hospitals NHS Foundation Trust Oxford UK

6. Ludwig Institute for Cancer Research University of Oxford Oxford UK

7. Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA

8. Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA

9. Department of Pathology and Laboratory Medicine University of Pennsylvania Philadelphia Pennsylvania USA

10. Genentech, Inc. South San Francisco California USA

11. F. Hoffmann‐La Roche, Ltd. Basel Switzerland

12. Guy's & St Thomas' NHS Foundation Trust London UK

13. Nuffield Division of Clinical Laboratory Sciences (NDCLS), Radcliffe Department of Medicine University of Oxford Oxford UK

Funder

Engineering and Physical Sciences Research Council

F. Hoffmann-La Roche

Cancer Research UK

Blood Cancer UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hem3.105

Reference14 articles.

1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

2. European consensus on grading bone marrow fibrosis and assessment of cellularity;Thiele J;Haematologica,2005

3. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

4. Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis – a consensus‐based study

5. The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading